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ABSTRACT

Objective: The genetic etiology for the majority of sutural growth disturbances,
in humans, is unknown. Therefore, the development of our knowledge of the genes
involved in suture fusion is essential for progress in the treatment of individuals with
cranial suture fusion disorders. In this study, we have examined Distal-Iess-5 (Dlx5), a
homeobox gene, which is required for Bone Morphogenic Protein (BMP)-mediated
osteoblast differentiation and is thought to play an important role in the development of
mineralized tissues. The significance ofDlx5 in these biologic processes has developed
interest in the role of this gene in cranial suture fusion. Methods: We examined the
expression of Dlx5 in the fusing and non-fusing cranial sutures of wild-type (wt) mice
by RT-PCR and immunohistochemistry. In order to determine the role ofDlx5 in the
cranial sutures, the Sagittal (S) and posterior frontal suture (PFS) were analyzed from
Dlx5 +/- and wild-type mice at postnatal day 10. To determine ifDlx5 +/- mice had a
decrease in osteoblast differentiation in the cranial sutures, Dlx5 +/- and wt mice were
bred with mice transgenic for the 2.3 kb fragment of the collagen Type I promoter fused
to a Green Fluorescent Protein (2.3 OFP). The 2.3 GFP promoter has been shown to be
an accurate marker of differentiated osteoblastic cells (Kalajzic et al., 2002). Results:
Dlx5 was abundantly expressed in the Sand PFS during sutural maturation (postnatal
day (10-45) and there was an increase in the expression ofDlx5 in the posterior frontal
suture (PFS) compared to the sagittal suture (S) at day 35. At day 10, there was an
increase in space (p< 0.05) between the parietal bone fronts in the sagittal suture from
Dlx5

compared to wt mice. Conclusiou: Genes involved, or thought to be involved,

in cranial suture fusion are of great interest among those studying both normal and
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abnormal calvarial development. Knowledge of the intricate processes and genes
responsible for proper growth of the cranium is essential to fmding therapies for
patients who are affected by disorders involving abnormal sutural fusion, namely
craniosynostosis. Evidence that a Dlx5 signaling pathway is involved in suture fusion,
may make available a new candidate gene for analysis in patients with these sutural
growth disturbances.

v

INTRODUCTION

Cranial sutures function as the major sites of bone expansion during postnatal
craniofacial growth and allow development of the skull to accommodate rapid growth
ofthe brain. For sutures to function as growth sites, they need to remain unossified, and
simultaneously allow formation of new bone at the edges of the overlapping bone
fronts. Too little or delayed bone growth at these sutures results in wide-open fontanels,
whereas too much or accelerated bone growth results in osseous obliteration of the
sutures (Opperman 2000).
Despite the obvious differences in human and murine craniofacial
characteristics, there is a marked similarity and conservation in the molecular pathways
for the assembly and growth ofthe cranial vault between the two species (Warren,
Greenwald et aL 2001). In mice, all the sutures of the cranial vault remain patent for the
life of the animal; except for the posterior frontal suture (PFS), which fuses in a
predictable manner between 21-45 days postnatal (Opperman 2000). In humans, the
equivalent metopic suture fuses within the first three years postnatal (Vu, Panchal et al.
2001; Weinzweig, Kirschner et aL 2003). Therefore, the murine PFS serves as an
excellent model of post-natal human sutural development (Warren, Greenwald et al.
2001).
BMP signaling has been linked to murine PFS fusion, and is expressed in
developing (Kim, Rice et al. 1998) and in adult murine cranial sutures (Warren, Brunet
et al. 2003). In fact, Warren et al. showed that inhibition ofthe BMP signaling
pathway, by adenovirus mis-expression ofthe BMP antagonist Noggin, blocks murine
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PFS fusion in vivo (Warren, Brunet et al. 2003). However, BMP added to murine
calvarial organ culture sutures did not cause sutural fusion (Kim, Rice et al. 1998).
Taken together, these results suggest that BMP is necessary but not sufficient for
murine calvarial suture fusion.
Many extracellular and intracellular proteins, such as Dlx5, regulate the BMP
signaling pathway. In an avian calvarial explant culture system, Dlx5 transcription was
upregulated by BMP and inhibited by the BMP antagonist Noggin (Holleville, Quilhac
et al. 2003) which proved that Dlx5 acts downstream from BMP signaling. In
subsequent investigations of osteoblastic cell cultures, it was shown that BMP causes an
increase in the expression of Dlx5 (Miyama, Yamada et al. 1999; Takagi, Kamiya et al.
2004), and that regulation of osteoblast differentiation by BMP is dependent on Dlx5.
Others showed, that in osteoblast-like cells, BMP can induce markers of osteoblast
differentiation including alkaline phosphatase (Kim, Lee et al. 2004), Runx2 (Lee, Kim
et al. 2003), and Osterix (Lee, Kwon et al. 2003) all of which have been shown to be
dependent upon Dlx5.

RATIONALE

The incidence of craniosynostosis in the United States is about .04-.1 %.
Although this developmental disorder is rare, it may result in severe malformations of
the cranial vault and in the more harshly affected, increased pressure on the brain. The
most detrimental consequences described are mental impairment, loss of hearing, and
poor vision. The severity of these complications requires that infants, sometimes at a
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young age, receive several surgeries to avoid further damage and to correct the
deformity.
The genetic etiology for the majority of sutural growth disturbances in humans
is unknown. Providing evidence that a Dlx5 signaling pathway is involved in sutural
fusion, may make available a new candidate gene for analysis in patients with sutural
growth disturbances.

HYPOTHESIS

In this study, we plan to examine the role of the transcription factor, Dlx5, in
controlling murine cranial suture development and growth. We hypothesize that Dlx5
expression will be increased in the murine PFS during the time of posterior frontal
suture fusion and that there will be a decrease in suture fusion in the PFS in
heterozygous Dlx5 (+1-) mice.

SPECIFIC AIMS/OBJECTIVES/PREDICTIONS

Aim 1. Examine the expression and localization of Db5 in the posterior
frontal and the sagittal cranial sutures.
The posterior frontal suture in mice fuses between days 21 and 45 postnatally.
Our working hypothesis is that Dlx5 expression will increase in the PFS during the
period of expected suture fusion (days 21-45 postnatal) relative to that in the non-fusing
sagittal suture. We plan on testing this hypothesis by examining expression levels of
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DlxS by RT-PCR and its localization by immunohistochemistry in the posterior frontal
and sagittal sutures from CD-lmice postnatal day 21, 2S, 3S, and 4S.

Aim 2. Examine the posterior frontal and sagittal sutures of 10 day-old
wild-type and heterozygous Dlx5 (+1-) mice.
Previous studies have shown that mice deficient in both alleles (DlxS -/-), die in
utero, therefore we plan on examining heterozygous DlxS

mice. In order for PF

sutural fusion to occur, the bone fronts ofthe frontal bone must come in contact with
each other, which occurs prior to PFS sutural fusion (postnatal day 21-4S). Therefore,
our objective is to determine the extent of bone front spacing in the posterior frontal and
sagittal sutures of 10 day-old wild-type and heterozygous DlxS (+/-) mice. Our working
hypothesis is that there will be an increase in the space between bone fronts in the PFS
in heterozygous DlxS (+/-) mice.

BACKGROUND

A. Cranial Sutures
The skull vault is composed of paired frontal, parietal, squamosal portions of the
temporal bones, and the anterior portion of the occipital bone. (Couly et al., 1993; Jiang

et al., 2002; Noden, 1978, 1988). These bones form the calvaria and develop through
intramembranous ossification; whereas, the bones that form the base of the skull
develop through endochondral ossification (Morriss-Kay and Wilkie 200S).
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In vertebrates, the skull develops from either neural crest, or mesodermal
tissues. Chai et al. and Jiang et al., incorporated markers in mice that enabled
visualization of the migration of cranial neural crest cells during development (Chai et
aI., 2000 and Jiang et al. 2000, 2002). These studies showed that neural crest cells
emigrate as three separate populations: the trigeminal crest, the hyoid crest, and the
vagal crest. The trigeminal crest migrates to the frontonasal and first branchial arch
regions and provides the neural crest component of the trigeminal ganglion; this is the
only popUlation of neural crest cells that contributes to the skull.
Cranial sutures separate the bones of the calvariae and form as the bony edges
meet. Growth at these sutures occurs perpendicular to the orientation of the suture;
normally, it coincides with the expansion ofthe brain (Morriss-Kay and Wilkie 2005).
At birth, the cranial sutures are patent and the flexibility that results allows the bones of
the cranium to overlap as the baby passes through the birth canal. Another significant
task of the cranial sutures is their role as the primary sites of bone growth during
craniofacial development. This is most notable during the period when the brain is
rapidly expanding (Baer, 1954).
The human metopic suture undergoes fusion during the first three years and all
of the other cranial sutures remain patent well into adulthood (Weinzweig et al., 2003).
In the mouse, the PFS, equivalent to the metopic or interfrontal suture in humans, fuses
in the first 45 days oflife. However, all of the other sutures, including the sagittal and
coronal, remain patent (Warren et at. 2001). Similarities between mice and humans in
craniofacial development, the specific molecules involved, as well as the structure of
those molecules make the murine posterior frontal suture an excellent model for the
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study of human suture development and pathology (Richtsmeier et ai., 2000; Schneider
et al., 1999; Waterston et al., 2002; Wilkie and Morriss-Kay, 2001).

B.Dura
The presence of the dura mater has been found to be essential for normal
development and maintenance of cranial vault sutures (Opperman et aI., 2005). In fact,
the ability of neonatal dura mater to regenerate bone has been observed clinically and
demonstrated in several animal models (Lenton et ai., 2005). For example, it has been
shown that the presence of intact dura is required for regeneration of the skull vault
after removal of a small area of the calvaria in infants and young animals (Babler et at.,
1982; Mabbutt and Kokich, 1979; Mabbutt et al., 1979; Mossaz and Kokich, 1981).
These findings and the intimate association between the dura mater and crania] sutures,
initiated investigations by others, to determine a role for dura mater in suture
development and fate (Lenton et al. ,2005).
Opperman et al. transplanted embryonic and postnatal corona] sutures with and
without dura mater to the midparietal bones of syngeneic adult rats and showed that
both embryonic and postnatal suture explants fused in the absence of their original,
suture-associated dura mater. On the other hand, explants of both sutures transplanted
with their dura mater intact remained patent (Opperman et aI., 1993). Similar results
were obtained when the embryonic sutures were placed in an in vitro organ culture
system, with intact sutures remaining patent and those lacking their dura mater fusing
(Opperman et at., 1995). These results suggested that factors and/or physical signals
from the dura mater associated with the coronal suture are responsible in some way for
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maintaining suture patency in the late embryonic and early postnatal stages of
development.
In subsequent studies, Opperman and colleagues added conditioned media from
dura mater cultures to coronal suture explants placed in organ culture without their
suture-associated dura mater. They showed that this conditioned media was capable of
preventing suture fusion. When the media was divided into heparin and non-heparin
binding fractions, only the heparin-binding was capable of maintaining coronal suture
patency (Opperman et ai., 1996). These results suggested that heparin-binding growth
factors, such as FGFs and Transforming Growth Factor-fJ (TGF-fJ) superfamily
members, were responsible for differences in coronal suture fate (Opperman, et al.,
1996).
The role of the dura mater in maintenance of suture patency has also been
demonstrated in the sagittal suture (Kim et al., 1998). Embryonic (EI6) murine sagittal
suture explants that were cultured without their dura mater, fused within three days; this
contrasted with control explants, cultured with their dura intact, that remained patent.
However, no difference was demonstrated in the patency of sagittal suture explants
from postnatal (PI) mice cultured with and without their associated dura mater (Kim et

al., 1998). This prompted investigators such as Kim et al. to study the expression of
genes known to act in conserved signaling pathways throughout development. Different
patterns of expression of these genes were found at the end of embryonic development
in the osteogenic fronts of the sagittal suture. This suggested that different molecular
mechanisms are responsible for suture morphogenesis during the embryonic and
postnatal stages of development and lead to the hypothesis that in the murine sagittal
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suture, the dura mater is responsible for maintaining suture patency prior to birth, while
molecular signals from the osteogenic bone fronts are the principal regulators of suture
patency during the neonatal stages of development (Kim et al., 1998).
Other studies have focused on the effects of removal or disruption of the dura on
PFS fusion. Separating the dura mater from the overlying PFS either temporarily or by
placement of an impermeable silicone membrane, resulted in a significant delay in
fusion of the PFS and suggested that there are interactions between the PFS and the
dura during the process ofPFS fusion (Roth et al., 1996).
Verification that molecules originating in the dura mater were responsible for
coronal and sagittal suture patency, as well as PFS fusion, led to the hypothesis that the
dura mater has a specific "make -up", based upon it's location, and is therefore capable
of coordinating the differing fate of each cranial suture (Lenton et al., 2005). Levine et

al. (1998) tested this hypothesis by removing a portion of the calvariae, in rats,
containing both the posterior frontal and sagittal sutures without the dura mater and
rotated it 1800 • This placed the dura that was previously associated with the PFS in
contact with the sagittal suture and vice versa. The new position resulted in obliteration
of the sagittal suture which normally remains patent and sustained patency of the
normally fused PFS in vivo.
The results of these experiments clearly indicate a role of the dura mater in
determining cranial suture fate.

C. Disturbances in Suture Fusion

For sutures to function as growth sites, they need to remain patent, and allow new
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bone to be formed at the edges of the overlapping bone fronts. Too much or accelerated
bone growth results in osseous obliteration of the sutures; whereas too little or delayed
bone growth results in wide-open fontanels (Opperman 2000).
1. Craniosynostosis, or premature fusion of the cranial sutures, results in an

abnormal skull shape, and may cause severe deformities such as blindness and mental
retardation (McCarthy et at., 1989). Although the majority of craniosynostoses are
nonsyndromic, more than 100 different syndromes have been identified that include
craniosynostosis as one of their many characteristics (Wilkie, 1997). Because
craniosynostosis is such a common finding among syndromes and may result in severe
deformities, it is important to study the mechanisms and roles of the molecules involved
in cranial suture fusion in an effort to develop therapies to treat the disorder.
In the last ten years, some of the more common syndromes of these have been
linked to dominant mutations in genes encoding Fibroblast Growth Factor Receptors
(FGFR1, FGFR2, and FGFR3), and the transcription factors TWIST and Msx-2 (Bellus

et at., 1996; EI Ghouzzi et at., 1997; Howard et at., 1997; Jabs et at., 1994, 1993;
Oldridge et at., 1995; Reardon and Winter, 1994). Mutations ofFGFRs and Msx-2
genes are usually described as gain-of-function mutations whereas TWIST mutations
are known as loss-of-function mutations. (Opperman et at.,2000). Mutations in these
genes and transcription factors account for about 25% of all cases of craniosynostosis
(Twigg et at., 2004).
Msx-2 (muscle segment homeobox 2) is a highly conserved homeobox gene that

is involved in the regulation of inductive tissue interactions during embryogenesis (Jabs

et at., 1993). A mutation ofthe Msx-2 gene was the first to be identified among gene
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mutations associated with craniosynostosis (Jabs et al., 1993). Boston-type
craniosynostosis is the only syndrome with craniosynostosis that is associated with
mutations in the gene for Msx-2 (Jabs et al., 1993). The specific mutation associated
with Boston-type craniosynostosis is a cysteine to adenosine transversion on the gene
for Msx-2 that leads to an amino acid substitution. (Jabs et al., 1993), this results in an
increase in DNA-binding ofthe Msx-2 protein and augmentation of the normal function
ofMsx-2 (Ma et al., 1996).

TWIST is a transcription factor that was originally identified as a principal
stimulator of mesoderm formation in Drosophila (Lenton et al., 2005). Mutations in the
gene encoding TWIST are also associated with craniosynostosis among many other
abnormalities. Heterozygous TWIST-l mutations have been identified in 80% of
patients with Saethre-Chotzen syndrome (Chun et al., 2002; Johnson et al., 1998).
Some of the many abnormalities found in patients diagnosed with this disorder are,
craniosynostosis involving one or both coronal sutures, midface hypoplasia, and facial
asymmetry (El Ghouzzi et al., 1997; Johnson et al., 1998; Reardon and Winter, 1994).
In contrast to the Msx-2 gain-of-function or overexpression mutation, the majority of
TWIST-1 mutations resulting in craniosynostosis, produce haploinsufficiency and result
in a lack of functional protein production (Paznekas et al., 1998; El Ghouzzi et al.,
1997).
Heterozygous FGFR mutations are the most common genetic abnormality
associated with syndromes including craniosynostosis in their phenotype (Lenton et al.,
2005). The most frequently occurring mutations are missense, or small in-frame
insertions or deletions that affect the ligand-binding domain (Wilkie, 1997). Other

10

mutations involve the tyrosine kinase domain of the isofonn FGFR2 and are thought to
have an impact on downstream signaling pathways (Kan et a/., 2002). However, most
mutations of this gene are dominant and are believed to result in a gain of function by
either increasing ligand binding affinity, decreasing the specificity of receptor-ligand
interactions, or increased receptor dimerization and stabilization (Lenton et a/., 2005).
Most of the FGFR mutations that cause craniosynostotic syndromes are
mutations of the FGFR2 isoform. In fact, two mutations that result in an increase in
function account for almost all of the cases of Apert syndrome (Lenton et a/., 2005). In
addition, other mutations of the FGFR2 gene have been associated with Pfeiffer and
Crouzon syndromes. An analogous mutation, to one found in the gene encoding FGFR2
that causes Apert syndrome, has been identified in the FGFRI gene, and is responsible
for some cases of Pfeiffer syndrome (Robin et a/., 1994; Wilkie et a/., 1995). Two
mutations in the FGFR3 gene have been linked to Muenke syndrome and type I
thanatophoric dysplasia (Bellus et aI., 1996; Muenke et a/., 1997, 1994; Tavonnina et
a/., 1995).
2. Enlarged Parietal Foramina
Too little sutural growth results in a disease known as Enlarged Parietal
Foramina. Loss-of-function mutations in the transcription factors Alx-4 and Msx-2 have
been associated with this disorder among many others in development.
Alx-4 and Msx-2 encode homeodomain transcription factors known to have
regulatory roles in the development of various parts of the body in vertebrates (Alappat
et a/., 1999; Meijlink et a/., 1999). Studies of Alx-4 and Msx-2 knock out mice have
displayed the importance of their roles in skeletal patterning, differentiation, and
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growth. These mice had craniofacial, axial, and appendicular abnormalities among their
many defects (Antonopoulou et al., 2004; Qu et al., 1997; Satokata et al., 2000).
In humans, heterozygous loss-of-function mutations of either of these genes may
result in defects of the skull vault in the form of enlarged parietal foramina (PFM)
(Mavrogiannis et al., 2006). Typical PFM are bilateral oval or round openings in the
parietal bones on either side ofthe posterior frontal suture (O'Rhailly et al., 1952).
They are easily distinguished from the normally present minute foramina that blood
vessels run through (Tubbs et al., 2003), and are a result of delayed ossification during
rapid calvarial expansion (Antonopoulou et al., 2004; Satokata et al., 2000). Frequently,
PFM can be traced back to a defect in infancy that extends between the anterior and
posterior fontanelles; when this persists, it is termed cranium bifidum (CB)
(Mavrogiannis et al., 2006). A bridge of bone usually develops along the midline, that
creates two separate foramina, which usually decrease in size with age through
circumferential bone growth Eventually, complete closure may occur, leading to clinical
nonpenetrance (Mavrogiannis et al., 2006).

D. Members of the TGF-beta superfamily and the regulation of cranial sutural
fusion
The TGF-~ superfamily includes several molecules that are involved in
signaling and have vital roles in various processes throughout development, such as,
embryogenesis, tissue formation, and wound repair (Gold et al., 1997; Kingsley, 1994).
Some members of this family that have been found to be involved in cranial suture
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development are the

TGF-~

isoforms (1, 2 and 3), and Bone Morphogenetic Proteins

(BMPs).

l.BMP
Previous studies have shown, that BMP4 is expressed in the sagittal suture
mesenchyme and dura mater of embryonic mice (Kim et at., 1998). Further study of
postnatal sutures showed that BMP4 protein is localized to the suture mesenchyme and
osteogenic fronts in fusing posterior frontal and patent sagittal and coronal sutures
(Warren et at., 2003).
Since BMPs have been found in patent and fusing cranial sutures, Warren et al.
screened for BMP antagonist mRNAs before, during, and after the period of expected
suture fusion. They discovered the presence of Noggin in the patent sutures in all three
of these periods and almost no Noggin expression in the fusing PFS as early as the time
period prior to suture fusion (15d) (Warren et at., 2003).
Takao et aI., was the first to demonstrate the function of Noggin as a BMP
antagonist in cultured murine bone marrow stromal cells (Takao et aI., 1996). Noggin
protein was found to bind BMP4 with high affinity and inhibit BMP4 activity by
blocking its ability to bind to cognate cell-surface receptors (Zimmerman et at., 1996).
Noggin was originally described in the Xenopus and was found to playa role in
normal dorsal development (Smith and Harland, 1992). Further studies by Brunet et at.,
found that Noggin induces lateral mesodermal tissues to form more dorsal elements
including muscle, heart, and the pronephros. In addition to these roles, they also found
that Noggin was able to rescue dorsal patterning in ventralized embryos (Brunet et at.,
1998).
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Many of the roles identified for Noggin, oppose those known for BMPs, for
example, the role of BMP to rival ventralizing potential in a developing embryo. As a
result of these studies, recent work has looked further into the roles of Noggin and
suggested that it might play an important part in maintaining suture patency (Lenton et

al., 2005).
Recently, the BMP antagonist Noggin has been linked with FGF2 activity and
determination of suture fate (Warren et al., 2003). Only the dura of the PFS expresses
FGF2 mRNA and protein in vivo (Greenwald et al., 2000) and produces high levels of
FGF2 in culture. FGF2 disrupts Noggin induction in a dose-dependent fashion,
suggesting that environments with a high FGF2 concentration, such as the PFS, reduce
Noggin expression and enable suture fusion (Warren et al., 2003).
Further evidence which suggests that Noggin may be responsible in determining
suture fate is the 3 day old CD-I mice injected with a noggin adenovirus that had
widely patent posterior frontal sutures after 50 days (Warren et al., 2003).

E. Transcription factors associated with BMP-Signaling
1. DIx Genes

Dlx homeobox containing genes are mammalian homo logs of the Drosophila

Distal-less (Dll) gene. They are a group of six genes that are organized into pairs,
specifically, Dlx 112, Dlx 5/6, and Dlx 317 (Robledo et al., 2002). Mammalian Dlx
genes are expressed in the primitive craniofacial region, the developing brain, and
limbs, as well as, the apical ectodermal ridge (Robledo et aI., 2002). Dlx gene products
have a conserved 60 amino acid homeodomain and are members of a large family of
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DNA-binding transcription factors. They are believed to control the transcription of
genes that affect organogenesis for skeletal fonnation (Miyama et al. 1999).
Dlx5 has been coined by some to be a new candidate responsible for skull
fonnation (Depew et al., 1999; Acampora et al., 1999). Compared with their other
family members, Dlx5 and Dlx6 are uniquely localized to all skeletal tissues (Holleville

et aI., 2003). In fact, Acampora et al., found Dlx5 and Dlx6 in immature chondrocytes
and developing skull bones of embryonic mice and rats and in the periosteum of more
mature bones (Acampora et al., 1999).
Results from several in vivo studies have provided evidence that indicates the
involvement of the Dix family of homeodomain proteins in the regulation of osteoblast
differentiation and bone tissue-specific gene expression (Miyama et ai., 1999). Ryoo et

al., showed that among the Dlx genes, Dlx5 is a bone-inducing transcription factor that
is expressed in fetal rat calvarial cells in the later stages of osteoblast differentiation
(Ryoo et al., 1997). In addition, it has been shown, that forced expression of Dlx5 in
cultured cells leads to osteocalcin expression and a fully mineralized matrix (Lee et al.,
2003, Miyama et al., 1999, and Tadic et al., 2002). These results strongly suggest that
Dlx5 plays an important role in the development of mineralized tissues.
In an investigation of potential functional roles for Dlx5, Miyama et aI., isolated
Dlx5 as a BMP-inducible gene by differential display technique. Subsequently, they
demonstrated that mDlx5-transfected cells show a more mature osteoblast phenotype
when compared to parental MC3T3-El cells, suggesting that mDlx5 plays a role in
osteogenesis (Miyama et al., 1999). In the study, mDlx5-transfected cells showed higher
alkaline phosphatase activities, osteocalcin production, and mineralization of
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extracellular matrix, suggesting that mDlx5 is a positive regulator of osteoblast
differentiation.
In addition, when the time course ofmDlx5 mRNA induction ofMC3T3-El
cells was examined, transcripts of mDlx5 continuously occurred 48h past the time of
BMP treatment. It was proposed from these findings, that the mDlx5 gene product plays
an important role in the later stage of the differentiated osteoblast since osteoblast fate
has been clearly determined at this time (Miyama et at, 1999).
Recent investigations, showed that Runx2, a transcription factor that plays an
essential role in osteoblast differentiation and bone mineralization (Lee et al., 2005), as
well as alkaline phosphatase (ALP) expression, was induced, in the absence ofBMP-2
with forced expression ofDlx5 (Kim et al., 2004). Another fmding was that blocking of
Dlx5 completely inhibited BMP2-induced stimulation ofRunx2 and ALP expression.
These results proved, that Dlx5, is required as an upstream regulator of the expression
of Runx2 that is generated by BMP signaling and suggested that Dlx5 enhances ALP
expression by increasing Runx2 expression (Kim et al., 2004, and Holleville et

al., 2007).
Results of these studies have shown that Dlx5 is essential for BMP-mediated
osteoblast differentiation and have suggested that Dlx5 plays a role in the mature stages
of mineralization in skeletal tissue. These, and previous findings linking BMP signaling
to murine PFS fusion, in addition to its expression in developing (Kim et al., 1998) and
adult cranial sutures (Warren et al., 2003), has lead us to believe that Dlx5 may play an
important role in cranial suture fusion.
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Abstract
Biglyc.n (Bgn) and decorin (Ocn) arc highly expressed in numerous tissues in the craniofacial complex. However, their expression and
function in the cranial sutures are unknown. In order to study this, we first exa mined Ihe expression ofbiglycan and deeOl;n in the posterior irontal
suture (PFS). whicb predictably fuses between 21 and 45 days post-natal and in the non-fusing sagi1tal (S) suture from wild-type (WI) mice. Our
data showed tbal Bgn and Den were expressed in bolh cranial sutures. We Lhen characterized the cranial suture phenotype in Bgn deficient, DCIl
deficient, BgllIDcl1 double deficient, and Wt mice. At embryonic day 18 .5, alizarin red/ale ian blue stain ing showed !bat !be Bgn/DclI double
deficient mice bad hypomineralization of the trontal and patietal cmniofacial bOlles. Histological analysis of adult mice (45 - 60 days post,natal)
sbowed that the Bgn or Den deficient mice had no cranial sutUl'e abnormalities and immunohistochemistry staining showed incrc.1scd production
of Den in the PFS from Bgll deficient mice. To test possible compensation of Den in the Bgn de1ieient sutures, lVe examined the BgllIDcll double
deficient mice and found that they had impaired fusion of the PFS. Semi-quantitative RT-PCR analysis of RNA from 35 day-old mice revealed
increased expression of Bmp-4 and Dlx-5 in the PFS compared to their non-fusing S suture in Wt tissues and decreased expression of Dlx-5 in
both PF and S sutures in the Bgll/DclI double deficient mice compared to the \Vt mice. Fai lure of PFS fusion and hypomineralization of the
calvaria in the BgnlDcn double deficient mice demonstrates that these extracellular matrix proteoglyeans could have a role in controlling the
formation and growth of the cranial vault.
~";l 2006 Elsevier Inc. All rights reserved.
Keyword.,: Small proteoglycans: Biglycan; Decorin; Crania l s uture; Mouse

Introductiou
Biglycan (Bgn) and decorin (Dcn) are members of the small
leucine repeat proteog1ycan family (SLRP). Members of this
family are characterized by a small protein core, which consists
predominantly of leucine,rich repeaL~. There arc 13 known
members of this family that are divided into three classes
depending on their genomic organization and the similarity of
their amino acid sequences. Bgn and Den belong to the class I

• Corresponding author. Division of Orthodontics, School of Dent. I Medicine,
UCHC, Fannington, CT 06030, USA.
E'Jnuil address: Wadhwa@uchc.edu (S. Wadhwa).
8756-3282/$ , see front matter to 2006 El.evier Inc. All rights reserved.
doi: I 0.1 OJ 6ij.bone.2006.11 .003

18

type SLRP and are highly expressed in skeletal and connective
tissues [1 , 12, 14, 15.31]. The exact function of both Bgn and Den
is unknown; however, both can bind and modulate members of
the TGF-beta superfamily [II].
Bgll deficient mice have impaired post,nalal bone fonllation
which may be due to the ability of Bgn to modulate the actions
of Bone morphogenic proteins,214 (B1l1p,2f4) in osteoblastic
cells, potentially contributing to the failure to achieve peak bone
mass and early onset of osteoporosis [4,36]. Den deficient mice
do !lot have obvious skeletal defects, but instead, have skin
fragility which is hypothesized to be due to tile ability ofDcn to
modulate collagen fibril structure and intcgrity [7]. Because of
their similarity ill structure and tlleir overlapping expression in
skeletal and connective tissues, it is probable that Bgll and Den
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in the transgenic mice. We selected post-natal day 35 for our RT-l'CR analysis
because we wanted to evaluate whether there would be differences in gene
""pres.sion during the time of normal posterior frontal sutural fusion.

fimction redundantly. Support of this concept comes from the
analysis of Bgl/IDcl/ double deficient mice that have a more
severe phenotype in both long bone and skin [25] compared to
WI or singly deficient SLRP mice.
The purpose of this study was to examine the role orBgu and
Den in the craniofacial complex. In the craniofacial region, Bgn
and Den are present in teeth [22,28], periodontal tissues [21].
nasal cartilage [29], eye [8]. temporomandibular joint [18], the
developing mandible [16,35]. and tbe developing calvaria [35].
Despite their prevalence in numerous tissues of the craniofacial
complex, little is knowl] about their function in these tissues. In
order to examine this furlher and to eliminate potential
compensation of Den with Bgn, we examined whether a
craniofacial phenotype could be unmasked by creating Bgl//
Den double deficient mice and comparing thera to the single Bgn
deficient, single Dell deficient, and control Wt miee.
There is similarity and conservation in the molecular
pathways thai control the assembly and growth of the cranial
vault between humans and mice [33]. In mice. all the cranial
vault sutures remain opcn throughout the life span ofthe animal,
except for the posterior frontal suture (PFS), which fuses in a
predictable fashion between 21 and 45 days post-natal (25]. In
hltnlanS, the equivalent metopic suture fuses within the first 3
years post-natal [30,34]. Therefore. the mouse PFS serves as a
model of post-natal human sutuml growth [33]. Bmp-2f4
signaling has been linked to murine PFS fusion by Warren el al..
who showed that inhibition of the BnIP-2!4 signaling pathway
by adenovirus mis-expression of the Bmp antagonist Noggill
blocks mllfine PFS fusion in vivo [32]. Since both biglycan and
deeorin can modulate Bmp-2!4 signaling, we hypothesized that.
in their absence, there would be defective Bmp-2/4 signaling
and impaired PF sutlU1l1 fusion.
In this study, we found that Bgn and Den were expressed in
the fusing PFS and in the lion-fusing S suture in Wt mice. The
PFS in hoth Den deficient and Bgn deficient mice revealed no
defects. However, further examination of the PFS in the Bgn/
Dell double deficient mice showed a lack of PFS fusion ill a
mechanism that is potentially related to a decreased expression
of Dlx-5.

Sixty day.old mice were divided inlo four groups. WI. Bgll defICient, Den
deficient and Bgn/Dc'11 double deficient, "ith 3n 11 ~ 3 for each group, The mice
were sacrificed and the soft tl",ues on their heads were removed. The calvaria
were radiographed using a Faxitron MX-20 Specimen Radiography System
(Faxitron X"ay ('.orp., Wheeling. II... USA) al an energy of90 kV for 20 s. The
images were captured with Eastman Kodak ('.0. X-OMAT TL (Eastroan Kodak
('0., Rochester, NY, USA).
In order to detennine the optimal length of a rectangular box that could be
used to quantitate the amount of radio-opacity in the PFS. the length of the PFS
from 60 day-old WI, Bg/l deficient, Den deficient, and Bgn!De/T double deficient
mice wu, firsl measured. The mean length±the standard elTor of the PFS was
I 1.0",0,6 mm forWt, IOJ±O.3 mm from BglI deficient. JO.7±1.2 mm fromD"/t
deficient, and 11.1±0.3 mm foc Bb~liDc'11 double deficient mice. Evaluation of
diffurences among the memlS by analysis of variance (ANOVA) reve-aled that
there were no significant differences in the len gth ofthe PFS between the groups.
Therefore. a 10 mm by 3 mm rectangular box was used to measure the amount of
radio-opacity in the PFS from the different gmups, The amount of radio-upacity
in the PFS was quantitated by using Image J NIH IMAGE.

Experimental procedures

Histology alld immunohistochemistry

GeJ1(ffation of Bgn and Dell single and double deficient mice

WI. Dell deficient, Bgn deficient, and Bg/riD!" douhle deficient ntice were
sacrificed by CO2 inhalation at 35-45 days al\er birth, Calvaria were removed
and fixed for 2 weeks at room temperature in 10% IOmllllin. After being wasbed
in water for 5 min, they were decalcified in ronnie acid bone decalcifier solution
([mmunocal from Decal Corporation, Tallman. NY, USA) for 4 weeks.
Specimens "'..... II,en washed in water for 5 min and fixed for 3 days in butTered
zinc fonn.lin (Z-fiJ( from Anatech Ltd., Battle Creek. MI, USA) before being
classically processed for histology and sectioned coronally. Section. were stained
withH&E.
Tissue sections were deparaff'mized with xylene. Following rehydration with
decreasing ooncenlrolionsof ethanol. the sections wefI'lreated with 3% peroxide in
methanol fur20min loblockendogenous peroxidase activity. Iuordertoexposethe
antigen, section. were predigested in chondroitina", ABC (cat# KEOI502,
SeikagakuCorp, Tokyo, J."an) ata concentration of 0.015 unilslmlrorl bOI37"C.
Incubating the sections in 10% gnat serum fur 30 min reduced non-specific binding,
Sections were then incubated overnight at 4 0(' with primary antibody at a 1:200
dilution. Den and Bgn antibodies (respectively LF 113 and LF 106) were kind gift.
from Larry Filiher(NIOCR. NIH~ Biotinylated rabbil anti-goat secondary antibody

All experiments were performed under an instilulionaUy approved protoC{)]
for the use of animals in research (IiNIDCR-lRf'·98-0S8 and 01-151). Mice
deficient in Bgn and Den were generated by gene targeting in embryonic stem
cells as de=ibed previously [7.36]. Heterozygous 8gn!Dcn deficient mice were
produced by breeding a homozygous Bgn deficient female (B15Il-I-IDcn+I+)
with an Den
deficient male (Bgll+I/iIDcIl+/-);
deficient
males are
since the Bgn gene is located
chromosome and absent from the Y chromosome, F2 BgnlDen double deficient mice
were obtained by interbreeding Fl heterozygnus BgnJDeI/ deficient animals, In
order to maximize the number ofrlouble deficient mice obtained, the following
breeding scheme was tilled: Bgll O/-IDw+/- males were bred to BI,,'ll +/-IDcn+/females, The crauial vault "fthe mice was analyzed at embryonic day 1&.5. and
post-natal days 35, 42, and 60, We chose to examine 42 days and 60 days postnatal (Ill. posterior frontal SUIllre normally fuses hetween 21 and 4S days postnatal) hecause they represent time points during and well past normal PFS
closure which allowed us to evaluate ifthere was a delay or failure "fPFS fu,im>
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Gellotyping
All mice were genotyped for Bgn and De" alleles by PCR aualysis as
described [5], PeR products were resolved by electrophoresis through 1.8"1.
agarose gels. yielding bands of 212 bp for the WI Bgll allele, 310 bp for the
disrupted B15I1 allele. J61 bp for the WI Dell allele, and 2.~8 bp for the disrupted
Dell allele,

Alizarin red and alcUm bille staining of mice littermate.,
In our experimeJ1lal "I'Pmach, we used a breeding scheme that would
maximize the number of BgnJDcn double deficient mice, and lOr this reason,
we were ullable to obtain a humo:zygous WI mouse and BgllIDcn double dell·
cient mouse in the same liner. Therefore, hI this first part of the study. We used
(Bgn+!-iDcn+/+) mice as our controls. 18.5 d.r.c. linenn.les obtained from 5
litters were euthanized, and then their skin, muscle, and fat were =ved. The
animals were fixed in 100% ethanol for 4 days and then placed in _cerone for
3 days. Mice were tben stained with alizarin red (0,09%) and aleian blue (0.05%)
in a solution com.ioing ethanol, glacial acetic acid, and water (67:5:28) for
3 days. After staining, mouse samples were transferred to 1% KOH until their
soft ,issues were dissolved and then preserved in a 100% gtycerol [23].
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was used and visualized by a slrept.vidin- peroxidase solution io !he presence of

DCII double deficient embryos had severe hypominera1ization of

DAB chromagen. The negative control consisted of the above mentioned

the Ji'ontal and parietal bones (Figs. I A-D). Alizarin red and
alcian blue staining were also performed on two additional BglI/
Dell double deficient embryos along with two littermate
controls revealing similar results (data not shown).

procedures except for the substitution of the primary antibody with rabbitlgE.
The data presented in this paper were reproduced in at least 6 different
sections from two separate animals for each group. Serial sections through the

whole suture were obtained for each animal and observations were confirmed in
different interspaced serial sections chosen to coverlhe whole suture. In this way.
it was ensured that the reported observations were genuine and not local random
abnonnalities. ln each case, data from a single representative experiment are
shown.

Expression of Bgn alld Den ill the PFS aJ/d sagiJta/ su/ure /iom
WI mice

A time course for the expression of Bgn and Den was
determined in the PF and the S suhtre in WI mice at day 21, day
25, and day 35 post-natally by semi-quantitative RT-PCR. The
data indicated that mRNA encoding both biglycan and decorin
is abundantly expressed in both the posterior frontal and sagittal
suture during maruration (Fig. 2A). Since there appeared to be
increased expression of BglI mRNA in the PF compan:d to the S
sutnre during the late phases of PFS fusion. we repeated Ihe
cxpelimCllts two more times at day 35 post-natal. In the three
independent experiments from 35 day-old Wt mice, we found
that the ratio of Bgn mRNA expression in the PFS/S suture was
l.l ±O.3.
[n order to dctennine the precise localization of Bgn and Den
protein expression in the PFS and to evaluate possible
compensation at the protein level, immtUlohistochemistry for
Bgn and Den was pelfollUed in 42 day-old Wt and Bgo
deficient mice (Figs. 2B- E). [n the PFS from the Wt and Bgn
deficient mice, Den was found in the underlying dura (Figs. 2e,
E). [n the Wt mice, Dcn appeared to have a more restricted

isolalioll oflhe sulu,.e complexfor mRNA extraction
Posterior frontal (PF) and sag ittal (S) suture complexes (including the

associated dura mater, suture

mesenchyme~

and osteogeJJic fronl<;) were

harvested from 35 day-old male Wt (11 = 4) and BglI/Dc/l (11 = 2) double deficient
mice. Mice were eutb3Dized with carbon dioxide, and the posterior frontal and
sagittal suture complexes were isolated under a dissecting microscope as
previously described [241.

Semi-qual1litalive RT-PCR
RNA was extracted from the cranial suture material using Trizo.l·Reagent
(Molecular Research C enter. Cincinnati, OH) following the manufacture's

instructions. One microgram total RNA from the sample preparation was reverse
transcribed with 50 units of SuperScript II RT usillg random hexamer primers
(lnVitrogeo Life Technology, Carlsbad, CAl following the manufacturer' s
instructions. The primers used for amplification were designed with Primer 3
software (http://www-geno me.wi.mit.eclu/cgi-binlprimeriprimer3.cgi). The primers used for RT-PCR were for Gapdh 5' gagaggccetatcccaact3' (forward) 5'
gtgggtgcagcgaacUtat3'(reverse), for Bmp-4 5' ggtgggtttgcttccactta3' (forward)
and 5'atgggagcgagttgtgtacc3' (reverse), for DL<-5 5'ccgggacgctttaltagatg3'
(forward) and 5'tggacactatcaatggtgcc3' (reverse), for biglycan 5'acctgtccccttecatctct3' (fonvard) and 5 'ccgtgtgtgtgtgtgtgtgt3' (reverse), for decorin 5 ' ccoac·
ataactgcgatccct3'(forward) and 5'tgtccaagtggagucccte3'(reverse), and for l8s 5'
catgtggtgtgaggaaa3'(fOlward) and 5'gcccagagactcatttctt3'(reverse). J'CR was
performed using a hot start (with Taq Gold™, Applied Biosystems) at 95 'c for
10 min followed by 45 cycles (biglycan. decorin, 18s. and GAPDH) or 50 cycles
(Dlx-5 and Bmp-4) of I on," at 94 "C,20sat 57 'Caod 30s at 72 'C followed by
a 7 min extension at 70 "C. The reaction was chilled to 4 'C afterwards until it
was analyzed. Sixteen microliters of the PeR product and a I OO-bp DNA ladder
(Gibco BRL) were run in a 10% acrylamide gel (THE) buffer at 100 V. The
products separated by electrophoresis were visualized after ethidiuon bromide
staining under a UV light aod photographed in a single field of view with a
digital camera. IndiVIdual bands on digital micrographs of RT-PCR products
were analyzed by densitometer using ImageJ NlH IMAGE Intensity for Dl,·. 5,
Bgn. Den. and Bmp-4 was calculated as a percentage of densitometry values for
control bands of GapdJr or 18s. Each primer set was tested previously to assure
that amplification was in the linear range by analyzing amplification af s everal
different cycle numbers.

A

Control

B

BgnlDcn DKO

Statistical analysi"
Statistical significance of differences among means was detennined by
analysis of vanance (ANOVA) wid! post hoc comparison of mor e than two
means by the Bonferroni method using GraphPad Prism (San Diego , CAl.

c

f,ontal

~

D
fr~

parietal

&I'

Results
Alizarin red- alciall blue staining oj E 18.5 /itlermates
Alizarin red-alcian blue staining ofE 18.5 control (Bgn

t/ !

Control

DCI/+ it) was used as the control due to the inability to generate
a Wt and a BgnlDcn double deficient in the same litter) and
BgnlDcn double deficient littcnnales revealed that the Bgnl

8gnlDcn DKO

Fig. I. Alizarin red/a leian blue 'taining of E18.5 littermates. (A. C) Control
BgII+I-/DcII+/+ mice. (8, D) Bb~';Dm double deficient mice.
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35 d
PF
S

Dcn double deficient mice were examined. Faxitron analysis
showed that the Bgn/Dcn double deficient mice had a clear
absence of radio-opacity in the PFS. On the other hand.
calvaria obtained from 60 day-old Wt, Bgn deficient. and
Dcn deficieut mice, all had PFS that was radio-opaque (data
not sho\>,'I\). Quantification of the amount of radio-opacity in
the PFS by X-ray scanning and NIH-image analysis revealed
that it was significantly decreased in BgIIIDcll double
deficient mice compared to the other groups (p < 0.001)
(Fig. 3A). Besides a decrease in mineralization of the PFS.
the decrease in radio-opacity in the PFS from tlle BgIIIDclI
double deficient could also be due to a difference ill the
structure and curvature of the calvaria. To test this
possibility. coronal histological sections of the PFS from
45 day-old Bgn deficient (Fig. 3C), DCIl deficieut (Fig. 3D),
Bgn/Dcn double deficient (Fig. 3E), and Wt mice (Fig. JB)
were examined. This analysis revealed PFS patency only in
the BgnlDcn double deficient samples compared to the other
groups.
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Dcn KO BgnlDcn DKO

c

B

Suture

/
Fig. 2. Expression ofBgn and Den in cranial sutures. (A) Semi-quanlilative RTPCR analysis perfonned [or DCIl and Bgn on RNA extracted from the sagittal
(S) suture and Ihe posterior frontal suture (PFS) from 21,25. and 35 d.y-old
wild-type (Wt) mice. (B-E) Immunohistochemistry (brown) for biglycanlB. D)
and decorin (C, E) on coronal sections of the posterior frontal suture from
42 day-old Wt (B, C) and Bgll deficient mice (0. E). Sections were
counterstained with hematoxylin (blue).

expression pattem in the dura compared to BglI deficient mice
where it was found at a higher level and Ihroughout the
structure. In contrast, the PFS from the Dcn deficient mice had
no change in the localization of 8gn in the underlying dura
compared to Wt mice (data not shown). Negative controls
consisting of the substitution of the primary antibody with
rabbit IgE revealed no visible staining (data not shown).
Ana(vsis of the PFS jivm Bgn dejicient. Dcn deficient, BgIIIDcf/
Double deficient and WI mice

Tn order to detennine what role 8gn and Den deficiency
had on latcr developmental stages. 60 day-old Wt and Bgnl

E

Bone
Fig. 3. Analysis of radio-opacity and histology of the PFS from Wt. BglI
deficien~ DCII deficien~ and Bgl//Dcl/ double deficient mice. (A) Quantification of intensity of radio-opacity in lbe PFS from faxitron images of the
calvaria from 60 day·old WI. Bgl/ deficient. Dw deficient, and Bgll/ Dcl/
double deficient mice. Each point is the mean and SEM for 11 = 3 for each
group. 'Significant decrease in the intensity of radi<Hlpacity in the PFS from
the BgnlDcl/ double deficient mice compared to the other groups. p > O.OOI.
(B-E) H&E staining of corona l sections of the posterior frontal suture from
45 day-old Wt IB), BgJl deficient (C). Dw deficient (0), and Bgl/lDcl/ double
deficient (E) mice.
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WT

s

PF
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DKO
PF

Bmp-4
DIx-5
Gapdh

.......... - ... - .02
.55

.53
1.15

.19

o

.

.9 BmplGapdh

.15 DlxlGapdh

Fig. 4. Semi·quantitative RT-PCR perfonned for Bmp-4 and Dlx-5 on RNA
extracted from the sagiu.1 (S) suture and the posterior frontal suture (PFS) limn
35 day-old wild-type (Wt) and BgJlIDclI double deficient mice. RT-PCR of
Gapdh served as a Ilonnalizing control.

£>;pressioll ofBmp-4 alld Dlx-5 mRNA in PFS alld sagittal
suture from 35 day-old WI alld BgnlDcn double deficient mice

Because Bmp-2 /4 signaling has been previollsly implicated
in controlling PFS fusion [32], we examined the relative
expression levels ofBmp-4 mRNA, and the Bmp-4 target gene,
Dlx-5 mRNA [10], in our mouse model. Messenger RNA was
extracted from the fusing PFS and non-fusing S sutures of
35 day-old Wt and in BgnlDcl1 double deficient and analyzed
by semi-quantitative RT-PCR These analyses showed that
Bmp-4 mRNA levels were higher in the (fusing) PFS compared
to S suture in both genotypcs. Intcrestingly, whcn Dlx-5 was
measured in the same samples, it was significantly highcr in the
Wt PFS compared to the S suturc but absent in both Sand PF
sutures in BgnlDcn deficient mice (Fig. 4). Similar results were
obtained in a second independently repeated experiment (data
not shown).
Discussion
This report shows that both biglycan (Bgn) and decorin (Dcn)
are abundantly expressed in the cranial sutures of mice, with
overlapping yet distinct pattems of expression in the fusing
suture and the dura maIer. We found that BglllDc1/ double
deficient mice have open sutures and severe hypomineralization
of both frontal and parietal bones as early as E 18.5, while mice
singly deficient in Bgll or DCII have no suture fonnation defects.
Murine PFS fusion is controlled by a complex interaction
between many different types of cells, tissue types, and growth
factors. For example, Warren et a!. [32] has proposed that Fgf-2
secreted by the underlying dura causes a downregulation of
Noggin within the posterior frontal sutural cells that allows
Bmp-214 to interact with the bone fronts to cause fil~ion of the
PFS. For such orchestration of events to occur. therc must be
control of the localization and activity of the secreted growth
factors. Proteoglycans that could modulate the activity of
growth factors within thc extracellular matrix of the posterior
frontal suture may providc this control [26].
Scverallines of evidence link both Bgn and DCll to Bmp-2/4
activity. III a recent study, we found that Bgll deficient calvarial
osteoblast-like cells had less ccll surface Bmp-4 binding, which
led to reduced Bmp4 mediated osteoblast differentiation in
Bgl/ deficient calvarial osteoblast-like cells compared to Wt

865

controls [4]. Similar results have been noted in MC3T3-EI cellderived clones expressing higher or lower levels of biglYC3n
[27]. Den has been shown to modulate the actions ofBmp-2/4.
Specifically Bmp-2 induction of alkaline phosphatase was
diminishcd in DCII deficicnt myoblast cells compared to Wt
controls [9].
Bgo and Dcn are similar in structure and function and it is
possible that they function redundantly. Immunohistochemistry
revealed tllat, in the absence of Bgn, Den is upregulatcd
throughout the PFS. Dcn expression was restricted to the interior
portion of the dura in Wt mice but more evenly distributed
throughout thc underlying dura of the PFS in Bgl/ deficient mice.
We have also previously reported increased expression of Den in
Bgn deficient osteoblastic cell cultures [4]. Furthermore we
found that the ability of Bmp-2 to induce mineralization, as
measured by alizarin red accumulation, was decreased 52% in
osteoblast-like cells from BgnlDcll double deficient mice [2]
compared to 30% in Bgl/ only deficient osteoblast-like cells [4].
We hypothesize that the impaired PFS in the BgnlDcl1
double deficient mice is due to altered Bmp-4 signaling sincc
we found equivalent mRNA expression of Bmp-4 but marked
reduction of Dlx-5 expression in the Bgnl DcII double deficient
cranial sutures. Many extracellular and intracellular proteins.
such as Dlx-5, regu1ale the Bmp-2/4 signaling pathway.
Specifically. Bmp-2 /4 has been shown to increa~e Dlx-5
cxpression in avian calvarial explant cultures [13] and in
osteoblastic cell cultures [10]. In addition, the Bmp-2!4
regulation of the osteoblast differentiation markers, RUIlX-2,
Osterix, and Alkaline phosphatase, appears to be dependent on
Dlx-5 [17, 19.20]. Impaired PFS fusion in the Bgnl Dcn donble
deficient mice may be due to failure of appropriate cxpression
of signaling molecules involved in promoting bone formation
and mineralization, which is consistent with previous findings
of severe osteopenia [2,5] and decreased expression ofDlx-5 in
the cranial sutures. However, as has been suggested by others, it
is important to consider the possibility that additional factors
besides increased or decreased bone formation could control
abnonnal cranial suture fusion [3,6].

Ta ble !
Summary of craniofacial anomalies in BglI. DCII, and BglI/DclI deficient mice
compared to Wt
Genotype

E 18.5
calvaria

Post-natal
PF fusion

Suture gene/protein
expressjon

Wt

Nonna!

Nonnal

DIx-5 and Bmp-4 mRNA
higher in PF vs. S

BgII deficient

ND

Nonnal

Den protein higher
in Bgn deficient
D ell deficient
Nonnal
Bgll protein unaffected
NO
BglIIDcn deficient Hypomineralized Patent suture Dlx-5 mRNA absent in
PF and S sutures
Nonna! WI mice and mice deficient in Bgn, Den, or both (genotype, column I)
were analyzed at embryonic day 18.5 (E 18.5) by alizarin red/alcian blue
staining (column 2) or post-natally (60 days after birth) by faxitron X-ray or
histology (column 3). Specific mRNA or protein .xpression in the normal and
mutant mice wa' examined in PF (posterior frontal) or sagittal (S) sutures 3545 days after birth (colwun4). ND~not detennined.
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In conclusion, we show that the alteration in the extraeellular
matrix of the posterior frontal suture causes impaired fusion
(Table I). These new data provide the fOlmdation for the
identification of novel candidate genes for patients who have
sutuml growth disturbances,
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Introduction
There are two main types of cranial suture growth disturbances. Too little or
delayed bone growth at these sutures results in wide-open fontanels and a human
disease known as enlarged parietal formania, whereas too much or accelerated bone
growth results in osseous obliteration of the sutures, and the human disease
craniosynostosis (Opperman 2000).
We have previously reported that in mice deficient in both biglycan and decorin,
there is lack of PFS fusion at 60 days. Analysis of gene expression in the PFS from 35
day-old wt and double deficient biglycanJdecorin mice, revealed equivalent expression
ofBMP-4, but a marked decrease in the expression of Dlx5 in the double deficient
mice. Therefore, we hypothesized that Dlx5 plays a role in PFS fusion. In order to test
this hypothesis, we examined the expression of Dlx5 in the cranial sutures from CD-l
mice and examined if a cranial suture phenotype was present in Dlx5

mIce.

In this study, we found that Dlx5 is abundantly expressed in both the sagittal and
PFS between 10 and 35 days postnatal. There was an increase in the expression of Dlx5
in the PFS compared to the sagittal suture at day 35. Examination of the cranial sutures
from Dlx5 +1- mice revealed no defects in PFS fusion, but instead an increase in the
distance between the parietal bone fronts in the sagittal suture. Taken together, these
results suggest that Dlx5 plays a role in postnatal growth of the sagittal suture in CD-l
mIce.
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Materials and Methods

To develop the mouse model for mice used in our experiments, Dlx5 transgenic
mice (Obtained from Dr Alex Lichler, UCllC, Farmington, CT) were bred with mice
transgenic for the 2.3 kb fragment of the collagen Type I promoter fused to a Green
Fluorescent Protein (2.3 GFP) (Obtained from Dr. David Rowe, UCHC, Farmington,
CT). The specific breeding pairs were Col I 2.3 GFP (+1+) Dlx5 (+1+) with
heterozygous Dlx5 (+1-), and Col 12.3 (+1+) heterozygous Dlx5 (+1-) with Col 12.3
GFP (+1+) Dlx5 (+1+). Heterozygous Dlx5 (+1-) 2.3 GFP (+1+) and homozygous Dlx5

(+1+) 2.3 GFP (+1+) littermates were analyzed.

Genotyping
All mice were genotyped for Dlx5 alleles by polymerase chain reaction (PCR)
analysis as described previously (Depew et a1. 1999). PCR products were resolved by
electrophoresis through 1% agarose gels, yielding a 368 bp band for the wt Dlx5 allele
and a 459 bp band for the disrupted Dlx5 allele. PCR products were visualized by
ethidium bromide staining under an ultraviolet light
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Histology and Immunohistochemistry

Frozen Embedding
Wild-type and heterozygous Dlx5 (+/-) mice were sacrificed by CO 2 inhalation
at 10 days after birth. Calvaria were removed and fixed for 2 weeks at room temperature
in 10% formalin. Next, they were separated into posterior frontal and sagittal regions
and placed in separate cassettes. After a 5 minute water wash, they were decalcified in
formic acid bone decalcifier solution (Immunocal from Decal Corporation, Tallman,
NY, USA) for 4 weeks. Specimens were then washed in water for 5 minutes and fixed
for 3 days in buffered zinc formalin (Z-fix from Anatech Ltd, Battle Creek, MI, USA).
Prior to embedding, a 200mI beaker containing 2-methylbutane was pre-chilled
over dry ice under a hood. Disposable base molds (Thermo Shandon) were filled with
frozen embedding medium (Thermo Shandon), care was taken to avoid the introduction
of bubbles. Posterior frontal and sagittal suture regions of the calvariae were immersed
in individual molds containing the embedding medium. The embedding media was flash
frozen by holding the mold with forceps in a solution of 2-methylbutane keeping the
embedding mold on a horizontal level. Once the medium was frozen, the mold was
allowed to sink to the bottom of the beaker until it was completely frozen. The molds
were removed from the methyl butane solution and wrapped in a square of aluminum
foil, placed in a plastic container, and stored at -20°C.
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CryoJane Frozen Section
Cryosectioning was perfonned on a Leica CMl900 Cryostat (D-69226; Leica,
Inc., Nussloch, Gennany) equipped with CryoJane Frozen Sectioning Kit (Instrumedics
Inc.; Hackensack, NJ). The CryoJane system is designed to capture a frozen cryostat
section on special cold adhesive tape to assist transferring the section to a cold glass
microscope slide coated with an ultraviolet light-curable, pressure-sensitive adhesive.
The section is pennanently bonded to the adhesive on the slide with a flash of
ultraviolet light.
The block containing either the decalcified posterior frontal or sagittal suture
was oriented in the block holder to obtain a

5-~

coronal section. After capturing the

frozen section on a piece of cold tape, the section was transferred to the cold slide, and
the transfer tape was removed, leaving the frozen section behind on the microscope
slide. The slides were air dried in the dark and kept in a slide box at 4°C before
process mg.

Fluorescent Imaging
Slides holding the frozen sections were soaked in IX PBS for 20 minutes then
mounted with cover slips using 50% glycerol in PBS. Col I 2.3 GFP was examined with
a microscope under ultraviolet light and pictures were taken with a color digital camera
at lOX magnification.
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Immunohistochemistry

Tissue sections were deparaffinized with xylene. Following rehydration with
graded ethanol, sections were treated in 3 % peroxide in methanol for 20 minutes to
block endogenous peroxidase activity. Next, sections were incubated in 10% goat
serum for 30 minutes to reduce non-specific binding and incubated overnight at 4° C
with primary antibody at a 1: 200 dilution. Dlx5 antibody was purchased from
Chemicon (Temecula, CA) cat #AB5728 and Biotinylated rabbit anti-goat was used as a
secondary antibody. Immunostaining was visualized by a streptavidin-peroxidase
solution in the presence of DAB chromagen. The negative control consisted of the
above mentioned procedures except for the substitution of the primary antibody with
rabbit IgE.

Semiquantitative RT-PCR

Posterior frontal and sagittal suture complexes, including the associated dura
mater, suture mesenchyme, and osteogenic fronts, were harvested from male wt mice.
Mice were euthanized with carbon dioxide, and the posterior frontal and sagittal suture
complexes will be isolated under a dissecting microscope as described by (Nacamuli,
Song et al. 2004). RNA was extracted from the calvarial sutures using Trizol-Reagent
(Molecular Research Center, Cincinnati, OH) following the manufacture's instructions.
One microgram total RNA from the sample preparation was reverse transcribed with 50
units of SuperScript II RT using random hexamer primers (InVitrogen Life Technology,
Carlsbad, CA) following the manufacturer's instructions. The primers used for
amplification were designed with Primer 3 software (http://www-
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genome.wi.mit.edulcgi-binlprimer/primer3.cgi). The primers used for RT-PCR were
5' gagaggccctatcccaact3 ' (forward) 5' gtgggtgcagcgaactttat3 ' (reverse) for 18S,
5' catgtggtgtgaggaaa3' (forward) and 5' gcccagagactcatttctt3 ' (reverse) for BMP-4, and
5'ccgggacgctttattagatg3' (forward) and 5'tggacactatcaatggtgcc3' (reverse) for Dlx5. The
reaction was chilled to 4°C until it was analyzed. Sixteen microlitres of the PCR
product and a 100-bp DNA ladder (Gibco BRL) were run in a 10% acrylamide gel
(TBE) buffer at 100 V. The products were separated by electrophoresis and visualized
after ethidium bromide staining under a UV light then photographed with a digital
camera. The RT-PCR procedure was repeated three times. Individual bands on digital
micrographs of RT-PCR products were analyzed by densitometer using Image J NIH
IMAGE. Intensity for Dlx5 and Bmp-4 was calculated as a percentage of densitometry
values for control bands of 18S.

Measuring the Width of the Sagittal and Posterior Frontal Sutures
H & E stained coronal sections of the posterior frontal and sagittal sutures from 10

day-old wt and heterozygous Dlx5 (+1-) mice were captured with a digital camera. In
Adobe Photoshop the distance between the bone fronts was measured in arbitrary units.
A micro-ruler was captured using the same digital camera, at the same magnification,
and arbitrary units were converted to Ilm by measurement against a known distance.

Statistical Analysis
Statistical significance of differences among means was determined by analysis
of variance with post-hoc comparison of more than two means by the Bonferroni
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method or the Mann-Whitney rank sum test for nonparametric populations using
SigmaStat (Jandel Scientific, San Rafael, CA).

Results

Dlx5 expression in cranial sutures

Immunohistochemistry for Dlx5 was performed in 10 day-old CD-l mice. In the
PFS from 10 day-old mice, Dlx5 expression was in the underlying dura and overlying
periosteum (Figure lA). A similar expression ofDlx5 was noted in the S compared to
the PFS (Figure IB).
A time course for the expression of Dlx5 and BMP-4 was determined in the
posterior frontal and sagittal sutures from CD-I mice at day 21, day 25, day 35, and day
45 postnatally by semi-quantitative RT -PCR. The data indicated that mRNA encoding
Dlx5 and BMP-4 were abundantly expressed in both the posterior frontal and sagittal
sutures during maturation (Figure 2). Since there appeared to be an increase in
expression ofDlx5 and BMP-4 mRNA in the PF compared to the S suture during the
late phases ofPFS fusion, we repeated the experiments two more times at day 35
postnatal. In three independent experiments from 35 day-old wt mice, the mean
decrease and standard error of Bmp-4 mRNA expression in the sagittal suture compared
to the PFS was 83 +/- 15%. Additionally, in three independent experiments from 35
day-old wt mice, the mean decrease and standard error of Dlx5 mRNA expression in the
sagittal compared to the PFS was 59

14 % (Figure 2 b).
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Analysis of the Posterior frontal and Sagittal sutures from 10 day-old heterozygous
Dlx5+/- andwt mice
Mice deficient in both Dlx5 alleles die shortly after birth and have almost a
complete absence of their calvaraie. In contrast, Dlx5 +/- heterozygous mice are viable.
In order for PF sutural fusion to occur, the bone fronts of the frontal bone must come in
contact with each other, which is expected to occur between 21 and 45 days postnatal.
However, we have observed this process of suture fusion beginning at a time point prior
to 21 days postnatal. Therefore, the cranial sutures from 10 day-old wt and Dlx5 +/were examined. H & E coronal sections of the Posterior frontal (Figure 3) and Sagittal
sutures (Figure 5) revealed that there appeared to be greater separation of the bony
fronts in the sagittal suture ofDlx5 +/- mice compared to wt mice. Measurement of the
distance between the bone fronts of the Posterior frontal and Sagittal sutures from 10
day-old wt (n=3) and Dlx5

mice (n=3), revealed a significant increase (p<.05) in the

distance between the parietal bone fronts in the sagittal suture from Dlx5 +/- compared
to wild-type controls (Figure 6). No significant differences were noted in the PFS
suture (Figure 4),

Osteoblast differentiation in the cranial sutures from 10 day- old heterozygous Dlx5 +/andwtmice
Dlx5 has been show to mediate osteoblast differentiation (Ryoo et ai., 1997),
therefore we hypothesized that there would be a decrease in osteoblast differentiation in
the cranial sutures from Dlx5

mice compared to wt mice. In order to examine this,

we bred Dlx5 +/- mice with mice transgenic for the 2.3 kb fragment of the collagen
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Type I promoter fused to a Green Fluorescent Protein (2.3 GFP). Previous investigators
have shown that the 2.3 GFP promoter is an accurate marker of differentiated
osteoblastic cells (Kalajzc et al.,2002). We have initial histological sections of the PFS
(Figure 7) and S suture (Figure 8) from 10 day-old Dlx5 +1+ 2.3 GFP and Dlx5

2.3

GFP mice. However, we have not analyzed the samples.

Discussion

Our experiments show that Dlx5 is expressed both in the fusing posterior frontal
and non-fusing sagittal sutures of mice during the time period of expected suture fusion.
Holleville et al. found, in chick calvariae, that Dlx5 is highly expressed at the
osteogenic fronts and at the edges of the suture mesenchyme, but not in the suture itself
(Holleville et aI., 2003). Data from Acampora et aI., who studied mice, also indicated
that the expression of Dlx5 was more pronounced in periosteal bone and was also
observed in endosteal cells (Acampora et al., 1999). These findings are similar although
some were found in chick embryos and others were found in mice. Our results also
showed that Dlx5 was expressed in the osteogenic fronts as well as the periosteum and
underying dura but not in the suture space.
In this study, we chose to use heterozygous Dlx5 (+1-) mice to investigate the
role ofDlx5 in cranial suture fusion due to previous findings that Dlx5 (-1-) mice are
affected by a severe phenotype. Depew et al. found that Dlx5 (-1-) mutants die shortly
after birth and approximately 25% of them are born exencepha1ic. The mutant mice
born without exencephaly have hypomineralized parietals and interparietals and all of
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the mutants had the phenotype of regional defects in their nasal and otic capsules
(Depew et al., 2005). Our results lacked a distinct phenotype in the PFS of Dlx5 (+1-)
mice. Previous reports from Depew et al. also recorded that no morphologic changes
were noted with the loss of a single Dlx5 allele. Therefore, it is very possible that the
phenotype of our heterozygous Dlx5 (+1-) mice was too mild for changes in fusion of
the PFS to be visible. In addition, several studies have shown evidence which might
suggest that other Dlx genes compensate when their family member is deficient. Dlx
homeobox genes are organized into pairs as follows: Dlx1l2, Dlx5/6, and Dlx
317(Robledo et al., 2002). Compared with their other family members, Dlx5 and Dlx6
are uniquely localized to all skeletal tissues (Holleville et al., 2003). In fact, Acampora
et al., found Dlx5 and Dlx6 in immature chondrocytes and developing skull bones of

embryonic mice and rats and in the periosteum of more mature bones (Acampora et al.,
1999). Robledo et aI., 2002 showed that there are redundant roles for Dlx5 and Dlx6
during osteogenesis in his study ofDlx5/6 (-1-) mice whose phenotype included a
complete lack of calvarial bones.
Developmental defects found in Dlx5 mutants that support our findings have
been described by Depew et al. in 1999. Scanning electron microscope analysis ofDlx5
homozygous mutant embryos revealed that a neural tube closure defect is centered in
the midbrain but also includes the forebrain and hindbrain in the more severe cases.
Examination ofthe calvarial roofs of non-exencephalic Dlx5 mutants revealed small,
hypomineralized parietal and interparietals (Depew et al., 1999). This developmental
phenotype, both in the specific areas of the brain, and in the parietal and interparietals
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of the Dlx5 mutants supports our findings in the sagittal sutures ofDlx5 heterozygous

(+1-) mice.
Another possible reason for the lack of phenotype that was seen in the PFS but
was seen in the sagittal suture from heterozygous Dlx5 (+1-) mice could be that PFS
fusion is dependent in part on sox-9 expression and a cartilage template (Sahar et aT.,
2005). The role of Dlx5 in chondrocyte differentiation is different than that in bone, and
this is why we propose that an obvious phenotype was not seen in the PFS. However,
we did appreciate a phenotype in the sagittal suture ofDlx5 heterozygous (+1-) mice;
this may be attributed to the lack of the necessity for a cartilage template in the sagittal
suture and the role ofDlx5 in regulating osteoblast differentiation (Sahar et aT., 2005 &
Ryoo et aT., 1997).
We hypothesize that the phenotype observed in the sagittal sutures ofD1x5 (+1-)
mice is due to a decrease in osteoblast differentiation compared to wt controls. In order
to test this hypothesis, we bred Dlx5 (+1-) mice with mice transgenic for the 2.3 kb
fragment of the collagen Type I promoter fused to a Green Fluorescent Protein (2.3
GFP). The 2.3 GFP promoter has been shown to be an accurate marker of differentiated
osteoblastic cells (Kalajzc et al., 2002). However, we have not analyzed the samples.
Although craniosynostosis is a rare finding, it may cause severe malformations
and developmental disorders in those that are affected. Since the genetic etiology is
unknown in the majority of human patients with sutural growth disturbances, evidence
that a Dlx5 signaling pathway is involved in cranial suture fusion, may provide a new
candidate gene for analysis in patients with sutural growth disturbances.
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The development of our knowledge of the genes involved in suture fusion is
essential for progress in the medical and genetic treatment of individuals with cranial
suture fusion disorders.
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Chapter 4

Discussion
Previously, our lab studied PFS fusion in biglycanldecorin double deficient
mice. In the study, we found that biglycan and decorin are highly expressed in fusing
cranial sutures as well as the dura in overlapping but distinct patterns. The double
deficient mice that were studied had patent sutures and severe hypomineralization of
frontal and parietal bones. However, mice deficient with either biglycan or dec orin
separately were absent of suture formation defects.
Similar to Dlx5, both Biglycan and Decorin have been linked to BMP2/4
activity. Recently, it was found that Biglycan deficient calvarial osteoblast-like cells
have less cell surface BMP4 binding. This led to a decrease in BMP4 mediated
osteoblast differentiation in the Biglycan deficient calvarial osteoblast-like cells
compared to the wild-type controls (Chen et al., 2004). Similarly, Parisuthiman et al.
found that MC3T3-E1 clonal cells expressing higher or lower levels ofbiglycan show
less BMP4 mediated osteoblast differentiation (Parisuthiman et at., 2005). Decorin has
also been shown to alter BMP2/4 activity. For example, Gutierrez et al showed a
decrease in BMP2 induction of alkaline phosphatase in decorin deficient myoblast cells
compared to wild-type controls (Gutierrez e aI., 2006).
In this previous study, we hypothesized that the deficiency in PFS fusion that
was observed in biglycanl dec orin double knock out mice was due to altered BMP4
signaling because we found equal amounts of mRNA expression of BMP4 but markedly
reduced expression of Dlx5 in the cranial sutures ofbiglycanldecorin double deficient
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mice. This finding drove our interest in studying the role ofDlx5 in cranial suture
fusion.
Our experiments show that Dlx5 is expressed both in the fusing posterior frontal
and non-fusing sagittal sutures of mice during the time period of expected suture fusion.
Holleville et al. found that Dlx5 is highly expressed at the osteogenic fronts and at the
edges of the suture mesenchyme, but not in the suture itself in chick calvariae
(Holleville et al., 2003). Although we studied murine sutures, we also found that Dlx5
was expressed in the osteogenic fronts as well as the periosteum and underying dura but
not in the suture space. We also found that 10 day-old heterozygous Dlx5 (+/-) mice had
increased space between their bony fronts in the sagittal suture compared to wt controls,
and that there was no apparent phenotype in the PFS from the Dlx5 (+/-) heterozygous
mIce.
Different models have been proposed in regards to the factors responsible for
Dlx5 expression in cranial sutures (Figure 9). Choi et al. found that the addition of
FGF2 to developing bone fronts in murine sutures stimulated BMP2 expression but that
the addition of BMP2 could not induce FGF2 expression. Another finding, was that
disruption ofRunx2 completely eliminated expression ofBMP2 and its downstream
genes Dlx5 and Msx2. These results suggested that Runx2 is required in addition to
FGF2 to work upstream ofBMP2 for the expression ofDlx5 (Choi et al.,2005).
Alternatively, Holleville et al. used a dominant-negative construct (DlxHD-EnR) that
interfered with chick Dlx5 transactivating activity in E6 calvaria cells transfected with a
constitutively active type I BMP receptor (AcBMPR). Results of their studies showed
that DlxHD-EnR prevents the induction ofRunx2 activation by BMP signals. They
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concluded that Dlx5 or related family members such as Dlx6 are necessary for the
initiation of Runx2 in immature chick calvaria mesenchyme triggered by BMP
signaling (Holleville et al., 2007). These results contrast with the findings ofChoi et aL
who found that Runx2 was involved in this cascade prior to activation ofBMP2/4.
Differences in the results obtained by these authors may be explained by their use of
animals from different species (Figure 9).
The increase in spacing between parietal bone fronts in the sagittal sutures from
Dlx5 (+1-) mice could be due to a decrease in osteoblast differentiation, changes in
apoptosis, and/or changes in proliferation in the sutural complex. Holleville et at.
recently showed that Dlx5 does not effect proliferation in immature calvarial cells
(Holleville et al.,2007). In addition, Acampora et al. (1999) showed no difference in
the apoptoic cells in a variety of tissues from the Dlx5 (-1-) compared to wt controls.
Therefore taken together, we hypothesize that increased spacing in the sagittal suture
seen in the Dlx5 (+1-) mice is due to a defect in osteoblast differentiation. In our study,
we started to examine differentiation by the use of mice transgenic for Col I 2.3 GFP,
however we have not finished analyzing the samples.

A. Future studies
Future studies may be useful in furthering our knowledge ofDlx5 and its role in
cranial suture fusion. Since a phenotype was observed only in the sagittal suture of
mutant mice, these studies may involve examining the proliferation, differentiation and
apoptosis of cells in the sagittal suture ofDlx5 mutant and wild-type mice.
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Additional studies that may enhance our knowledge of Dlx5 may be to knock
out the gene postnatally. Because the homozygous mutant has such a severe phenotype,
resulting sometimes in death at birth, we propose that the gene be knocked out
conditionally by flox Dlx5 and giving a tamoxifen cre postnatally. This would avoid the
problem of the lethal phenotype and still allow examination of the role of Dlx5 during
suture fusion.

B. Significance
Although craniosynostosis is a rare finding, it may cause severe malformations
and developmental disorders in those that are affected. Since the genetic etiology is
unknown in the vast majority of human patients with sutural growth disturbances,
evidence that a Dlx5 signaling pathway is involved in cranial suture fusion, may
provide a new candidate gene for analysis in patients with sutural growth disturbances.
The development of our knowledge of the genes involved in suture fusion is
essential for progress in the medical and genetic treatment of individuals with cranial
suture fusion disorders.
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Figure Legends
Figure 1. Expression of Dlx5 in the cranial sutures. Immunohistochemistry (brown) for
Dlx5 in the Posterior frontal suture (A) and Sagittal suture (B) from 10 day-old CD-l
wild-type mice. Sections were counterstained with Hemotoxylin (Blue).
Figure 2. Expression ofBMP4 and Dlx5 in the cranial sutures from 21 to 45 day old
wild-type mice. Semiquantitative RT-PCR analysis performed for BMP4~ Dlx5~ and the
house keeping gene 18S on RNA extracted from the posterior frontal and sagittal
sutures (A). Relative expression ofBMP4 and Dlx5 in the Sagittal/Posterior frontal
suture from 35 day-old wild-type mice. RT-PCR products separated by electrophoresis
were visualized after ethidium bromide staining under a UV light and photographed in a
single field of view with a digital camera. Individual bands on digital micrographs of
RT -PCR products were analyzed by densitometer usng Image J NIH IMAGE. Intensity
for Dlx5 and BMP4 was calculated as a percentage of densitometry values for control
bands of 18S. Each primer set was tested previously to assure that amplification was in
the linear range by analyzing amplification at several different cycle numbers (B).

Figure 3. H&E stained coronal sections of the posterior frontal suture from 10 day-old
wild-type(A) and heterozygous Dlx5 (+1-) (B) mice.
Figure 4. The mean distance in Ilm and standard error between osteogenic fronts of the
posterior frontal suture in 10 day-old Dlx5 (+1+) (mean=36.5; SE=21; n=3) and Dlx5
(+1-) (mean=78.1; SE=27.4;n=3) mice.
Figure S. H&E stained coronal sections of the sagittal suture from 10 day-old wild-type
(A) and heterozygous Dlx5 (+1-) (B) mice.
Figure 6. The mean distance in Ilm and standard error between parietal bone fronts of
the sagittal suture in 10 day-old Dlx5 (+1+) (mean=-45.9; SE=15.5; n=3) and Dlx5 (+1-)
(mean=69; SE=27.9;n=3) mce.
Figure 7. Transgenic Dlx5 (+1-) mice were bred with mice transgenic for the 2.3kb
fragment of the Collagen Type I alpha 1 promoter fused to a Green Fluorescent Protein
(2.3 GFP). GFP expression in the posterior frontal suture of 10 day-old Dlx5 (+1+)/2.3
GFP (+1-) (A) and Dlx5 (+1-)12.3 GFP (+1-) (B) mice.

Figure 8. Transgenic Dlx5 (+1-) mice were bred with mice transgenic for the 2.3kb
fragment of the Collagen Type I alpha 1 promoter fused to a Green Fluorescent Protein
(2.3 GFP). GFP expression in the sagittal suture of 10 day-old Dlx5 (+1+)/2.3 GFP (+1-)
(A) and Dlx5 (+1-)/2.3 GFP (+1-) (B) mice.

Figure 9. Proposed model of Dlx5 expression in cranial sutures
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